H3-K27me3(Histone 3 lysine 27 trimethylation) is a post-translational modification characterized by the tri-methylation of lysine 27 on histone H3. This epigenetic mark is associated with gene silencing and plays a crucial role in cellular differentiation and development. In pharmaceutical research, targeting H3-K27me3-modifying enzymes has emerged as a promising approach for treating various diseases, including cancer and neurological disorders. By modulating H3-K27me3 levels, novel therapeutics can potentially regulate gene expression and alter disease progression, offering new opportunities for drug development and personalized medicine.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.